发明名称 |
Un metodo para inhibir o reducir daño talamico en un sujeto afectado por esclerosis multiple que comprende la administracion de laquinimod; composicion farmaceutica. |
摘要 |
This invention provides methods for inhibiting or reducing thalamic damage in a subject comprising administering to the subject an amount of laquinimod, wherein the subject is a human patient afflicted with a form of multiple sclerosis or presenting a clinically isolated syndrome who has been determined to have thalamic damage at baseline, a subject afflicted with a disease or disorder other than a form of multiple sclerosis or a clinically isolated syndrome, or a subject not afflicted with a form of multiple sclerosis or a presenting clinically isolated syndrome, and laquinimod and laquinimod pharmaceutical compositions for use thereof. This invention also provides methods for inhibiting or reducing tremor or spasticity in a subject afflicted by tremor or spasticity, comprising administering to the subject an amount of laquinimod, and laquinimod and laquinimod pharmaceutical compositions for use thereof. |
申请公布号 |
CL2015000732(A1) |
申请公布日期 |
2015.08.07 |
申请号 |
CL20150000732 |
申请日期 |
2015.03.23 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
FILIPPI, MASSIMO;COMI, GIANCARLO;ROCCA, MARIA, ASSUNTA |
分类号 |
A61K31/4704;A61P25/00 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|